Leveraging Chinese demand for Australasian goods
Founded in 2010, QEX is a logistics company that facilitates trade between China and New Zealand (Australian office opening soon), aiming to be a one-stop shop for Australasian entities looking to export products to China. This includes nationwide pick-up, storage, packaging, customs clearance and delivery of products by Chinese consumers or through a daigou.
Many goods are much more expensive in China than elsewhere. In addition, Chinese consumers often prefer to source luxury and health products from overseas, with New Zealand and Australian health products being particularly desirable, stimulating import demand. A daigou is a channel whereby an entity outside China buys products in other markets on behalf of a customer in China. This is mostly for luxury goods, but increasingly other products are being imported. This is reflected in QEX’s rising sales of infant baby formula (demand for this in part reflecting Chinese consumer concerns over counterfeit goods and product safety). Daigous are widespread, with a significant percentage of Chinese consumers having used one to buy goods.
QEX’s main operations are:
■
Pick and pack services, and the export of health supplement parcels.
■
Supply, storage, repackaging and export of infant dairy products (sales in China and New Zealand).
■
Supply chain logistics.
■
Customs clearance services for items being exported to China from New Zealand.
■
Warehousing in Shanghai’s free trade zone.
■
Inventory management in New Zealand.
According to reports in the New Zealand Herald “QEX was the first cross-border logistics company in New Zealand to get risk management programme certification from the Ministry for Primary Industries, providing consumers with an assurance that their products are safe and authentic. It also offers a full traceability service”.
QEX has grown quickly from its inception in 2010 and reported revenues of NZ$22.2m in FY17 (year ending 31 March). The company’s growth was founded on logistics, easing customer journeys through establishing warehousing and co-ordination of customs routes. This led QEX to be one of the pre-eminent cross-border firms in New Zealand by 2013, helped by its risk management programme (RMP)-certified warehouses for e-commerce.
Growing demand for New Zealand products (including health supplements and diary/infant formula) fuelled further growth. QEX established its NZ subsidiary (New Y) to form relationships with manufacturers, offering bulk purchases and, as a result, clients started to purchase increasing amounts of supplements, infant formula and dairy products. Export volumes doubled in 2015 and revenues quadrupled.
The company plans to expand its business across a number of avenues. In New Zealand, investing in warehousing facilities will enable it to increase trading in its bulk products. QEX has recently moved to new warehouse facilities close to Auckland airport, increasing its footprint from 1,100m2 to 2,539m2 (while office space has increased to 515m2 from 100m2). Listing (and capital-raising) will give the company the ability to establish its Australian operations, and increase its client relationships and product range.
QEX’s Chinese subsidiary (Shanghai Ditu) will increase the group’s clearance capability to deal with the anticipated volumes from New Zealand and Australia. Equally, it is looking to enable the reverse flow of goods (from China to New Zealand/Australia).
Finally, in Australia, the new office opening in the first quarter of CY18 could mirror the success of QEX in New Zealand.
The company is headquartered in New Zealand and has subsidiaries in China and Australia.
New Y Trading, New Zealand
QEX’s New Zealand operations are dominated by three activities:
Health supplement parcels: every day, New Y collects health supplements and other items from souvenir stores and online warehouses in the Auckland area. Collections are also made from Hamilton, Palmerston North, Wellington, Christchurch and Queenstown. Once collected, items are packaged and exported to China, for a fee.
Warehousing and repacking: New Y provides a certified warehouse service in Auckland, providing export, logistics, repacking and storage services. Inventory ownership is retained by the clients, with New Y managing inventory.
Supply chain services: New Y supplies infant formula powder and baby food to customer specifications, saving money by buying in large quantities. It also allows customers to outsource the packaging, labelling and delivery of products to end-users in China. It also supplies logistics for large orders of New Zealand (and soon Australian) goods to Chinese end-users.
QEX’s Chinese subsidiary (Shanghai Ditu International Freight Forwarders) focuses on a number of operations:
Customs clearance services (Shanghai): Ditu provides clearance services for cross border parcels into China. It also has contracts with customs in Guangzhou, Chonqing, Chengdu, Tianjing, Kunming, Changsa, Ningbo and Xiamen. Ditu’s quick and efficient customs clearance has attracted customers in New Zealand, Australia, the US, the UK and Japan.
Manifest preparation and clearance: due to global time differences and to enable efficient customs clearance, Ditu prepares manifests for clients from data supplied by its customers. All manifests are prepared before the arrival of the product.
Customer service: Ditu provides 24/7 customer service to its clients including parcel tracking, local delivery logistics and customs interface.
Inventory management: Ditu’s bonded warehouse in the Shanghai Free Trade Zone (FTZ) allows orders to be received, repackaged and cleared through customs quickly for onward delivery.
Export service: QEX is looking to capitalise on the demand for goods made in China flowing to Australasia. As a result, it is working with the Chinese to provide services to export small parcels from China to New Zealand and Australia.
The daigou market in Australia is bigger than New Zealand and operates in a similar way, allowing QEX to capitalise on its knowledge and brand. It created an Australian subsidiary in October 2017 and plans to have a team in place in Melbourne by the end of March 2018. Initial focus will be on cross-border logistics services, specifically targeting dairy products and health supplements as per operations in New Zealand.
Free trade zones indicate daigou channels are here to stay
In April 2016, the Chinese government created a “positive list” for cross-border e-commerce to legitimise the grey market, adding 1,142 product categories that no longer require permits or registrations when being imported into China. These categories include many of the goods on which QEX focuses. Goods on this positive list are subject to reduced VAT of 11.9% on small transactions. If Chinese customers buy goods with a value lower than c $NZ400 (or c NZ$4,000 per year), lower taxes are levied.
QEX uses two channels to deliver products to Chinese consumers: (i) small parcels are collected and aggregated daily, and delivered through the Chinese postal services under the Chinese parcel tax scheme; and (ii) dairy products and infant formula are exported and delivered through the warehouse, where the goods go through a pre-clearance declaration (essentially moving the Chinese border to the FTZ). This system reduces lead times for delivery to Chinese customers, while import VAT and duty is not paid until the goods have left the warehouse.
China is the largest market for New Zealand’s goods (and second only to Australia in total exports). Nearly 16% of goods exported from New Zealand (worldwide) are dairy products. We note that New Zealand’s organic certification is recognised by China.
Exhibit 1: Top New Zealand export countries, 2016
|
|
|
Given the size and growth of the Chinese economy, we would expect it to make up an increasing percentage of New Zealand (and Australian) trade, especially given the improving relationship between them. Negotiations are underway to upgrade the free trade agreement between the two countries.
Exhibit 2: Total commodity exports from New Zealand, 2016
|
|
|
Client relationships and multiple sources
QEX has relationships with a wide range of New Zealand suppliers. These include:
A major supermarket chain: QEX has been contracted by a major Australasian supermarket chain to provide cross border logistics services for its online portal targeting Chinese consumers. The extent of the contract is confidential.
Sky Distribution (SDL) is the marketing company for Anmum infant formula, produced by Fonterra. QEX picked up SDL as a client in August 2017 to fulfil online sales in China, using QEX’s Chinese warehousing facilities.
Munchkin: QEX distributes Munchkin’s (goat-based) infant formula in New Zealand and Australia, using its warehousing infrastructure. The contract started in January 2017.
Fonterra Anchor: QEX distributes Anchor milk powder in New Zealand and China (it is the most recognised New Zealand drinking milk brand in China) through daigou channels. The contract started in January 2016.
Health Element 2009 has six stores in New Zealand focusing on Chinese daigou channels. QEX provides daily pick-up from Health Element stores and supply chain services. The contract started in January 2011.
Magic Lamp Group (Aladdin) is an online platform for New Zealand companies to sell direct to China. It has 70,000 consumers and 3,600 resellers (recruiting over 1,500 merchants in the past two years). QEX has provided logistics services since 2015.
EZ Health and Beauty supports the daigou channel for New Zealand health and beauty products. QEX has provided logistics services since 2011.
Whoo Team is a wholesaler and distributor of infant milk powder, for which QEX provides pick-and-pack and cross-border logistics.
Natural Line International sells New Zealand health/beauty and dairy products through Taobao, for which QEX provides pick-and-pack and cross-border logistics.
Kylin International sells infant formula (various brands) to the Chinese market via Taobao. The relationship started in 2013.
Nuxten NZ sells New Zealand foods and skincare products on Alibaba (and is a Gold Supplier). QEX has supplied services to Nuxten since 2016.
Best Choice: wholesaler and distributor of health and dairy products to China through e-commerce sites. QEX provides storage services (including FTZ warehouses) for Best Choice.
NatureGate is a wholesaler and distributor of health supplements and dairy products.
Newhealth provides health supplements to daigou customers.
Board: having Conor English and Danny Chan on the board is a major coup for QEX and their presence should help guide future growth, opening up new markets.
Relationship with suppliers: QEX is young but has grown its supplier base quickly. Recurring revenues and strong growth suggest it is providing good service to its suppliers and customers.
Bonded warehouse: The company’s bonded warehouse in China is a key strength, enabling QEX to deliver advantages to its clients that others cannot. The warehousing also gives the company the ability to buy in bulk on its own account, selling to Chinese clients as demand requires it, thereby making good margins. This also means it can help to serve the burgeoning e-commerce demand in China.
Distribution: the company relies on third parties for selected logistics operations. While it is not responsible for the operations of these companies, its reputation and business could be negatively affected by poor performance. Equally, reliance on these relationships could cause short-term issues if the contracts between the companies are troubled or terminated. However, it is confident that suitable alternative companies could be sourced at similar rates/costs.
Competition: There are hundreds (if not thousands) of daigous serving Chinese consumers and the exact number in New Zealand/Australia is not known. QEX may therefore face strong competition in the coming years.
Economies of scale: QEX is small and relies on a large number of (presumably small) contract values, which means it cannot (yet) deliver increasing economies of scale with much larger order sizes.
Vast market: The Chinese market is vast, and should provide growth potential for QEX if it can deliver on its geographic and product diversification programme. The addition of a large supermarket chain gives us increasing confidence that the company can enhance its presence further. Successful execution of the supermarket channel could materially boost volumes and help build a sizeable reputation in New Zealand.
Australia: Australia is another huge potential source of goods for Chinese consumers, and QEX’s move to open new operations in Melbourne is a good one.
Geographic concentration: the company is entirely focused on cross-border trade with China. As a result, any changes in regulatory environment in relation to trading between China and New Zealand/Australia could have a material effect on revenues.
Product concentration: in the year ended 31 March 2017, more than 50% of revenues were derived from sales of infant formula and other dairy products. As a result, the company would be sensitive to any events that affect the sales of dairy in China (such as tariffs, foreign exchange movements or health issues). The company expects this reliance to reduce over time as it increases the range of products it trades and opens up markets in Australia.
Foreign exchange: despite the majority of revenues being driven by sales to China, the overwhelming balance of its currency exposure is to New Zealand dollars (only 2% of sales are in renminbi). This will likely change as the Australian operations ramp up and, perhaps, as Chinese operations mature.
Taxes, legislation and regulation: as a trading company, any changes in regulations, operations, tariffs or laws guiding exports and imports from/to China may have a significant effect on the company’s operations. At the moment, we believe New Zealand/Australia and China all see mutual benefits in lowering barriers to trade, as evidenced by the free trade zones first set up in China in 2013, which now number 11 across the country.
Daigou status: there are risks of state clamp-down on the daigou channels, but we do not think this is likely at this point, due to the setting up of the FTZ.
Independent chairman: Conor English is an experienced director with many years’ experience and brings expertise in exports, a range of international networks and relationships to QEX. He is currently chairman of Agribusiness New Zealand (which focuses on exports and trading, farm systems, smart city technologies, and agricultural and technology investment). Its exports markets include China.
He acts as an independent advisor to the Reserve Bank of New Zealand (one of only two external independent advisors). He is a director of GMP Pharmaceuticals Group, a leading privately owned Australia- and New Zealand-based manufacturing company specialising in complementary healthcare products, natural health and dairy products. GMP’s pharmaceutical-grade facilities in Sydney and Auckland service clients both locally and in over 30 countries around the world.
He has directorships of Silvereye, the New Zealand eSports Foundation and is a board member of the Live Animal and Germplasm Trade Association. Mr English holds 500k options.
Chief executive officer: Jingje “Ronnie” Xue was born in Suzhou, China and received a Master’s from Monash University (Melbourne). He started his logistics career at Australian National Line, one of Australia’s leading shipping companies. In 2010, Ronnie moved to New Zealand and started what has now become QEX Logistics. Under his leadership, New Y Trading was ranked 42nd in the Deloitte Fast 50 in 2016 and 13th in 2017.
Mr Xue currently holds 80% (or 40m) of QEX’s shares.
Independent director: Danny Chan holds a number of directorships in New Zealand. He is a director of Academic Colleges Group and an independent director of Abano Healthcare. He also holds positions at Flowerzone International, Auckland Tourism Events and Economic Development, Farmers’ Mutual Group and Marlborough Wine Estates. Throughout his career, Mr Chan has developed an extensive network of contacts in both New Zealand and Asia, and is fluent in Mandarin and Cantonese. Danny acts as an advisor for several New Zealand companies for their Asia marketing and joint venture operations. He is a member of the Institute of Chartered Accountants of New Zealand and a member of the Cost and Management Association. He is also a fellow of the CFA Society New Zealand and a member of the Institute of Directors. Danny is a member of the NZ-China Executive Advisory Council and a director of the Asia New Zealand Foundation - Confucius Institute. He is also a member of the New Zealand Stock Exchange’s Markets Disciplinary Tribunal. Mr Chan holds 500k options.
QEX remains a small company and has few peers. We note that AuMake (a recently listed Australian company) is approaching the daigou market differently, planning to open at least 20 specialist stores in Australia targeting Chinese consumers. It currently has no revenues, but raised A$14m on 22 January 2018.
There are a number of other logistics companies globally, which average 12.8x next year EV/EBITDA multiples. As can be seen, analyst coverage of these is poor for any companies with market caps of less than c US$700m.
Exhibit 3: Comparative multiples
|
Market cap (US$m) |
EV/EBITDA (x) trailing 12 months |
P/E (x) trailing 12 months |
Direct |
|
|
|
AuMake International |
84 |
- |
- |
|
|
|
|
Milk and health supplements |
|
|
|
a2 Milk Co |
4,645 |
19.4 |
70.7 |
Bellamy's Australia |
1,275 |
- |
- |
Blackmores |
2,047 |
17.6 |
44.4 |
Median |
|
18.5 |
57.6 |
. |
|
|
|
Logistics |
|
|
|
United Parcel Service |
96,818 |
12.1 |
18.7 |
FedEx Corp |
67,021 |
9.3 |
20.6 |
Deutsche Post |
56,545 |
9.7 |
17.7 |
Kuehne + Nagel International |
21,139 |
18.5 |
27.8 |
Bollore SA |
16,026 |
25.6 |
44.8 |
DSV A/S |
14,996 |
19.5 |
28.1 |
JB Hunt Transport Services |
12,724 |
13.6 |
30.4 |
CH Robinson Worldwide |
12,654 |
15.6 |
26.8 |
Expeditors International of Washington |
10,994 |
13.3 |
26.0 |
Yamato Holdings |
10,503 |
18.7 |
- |
Nippon Express |
6,673 |
7.6 |
15.1 |
Hyundai Glovis |
4,964 |
6.9 |
11.4 |
Landstar System |
4,658 |
14.9 |
29.6 |
Panalpina Welttransport Holding |
3,780 |
23.5 |
50.7 |
Sinotrans |
3,427 |
7.2 |
12.9 |
Sankyu |
3,074 |
7.2 |
15.6 |
Hitachi Transport System |
2,773 |
10.2 |
15.7 |
Mainfreight |
1,900 |
14.1 |
25.3 |
Forward Air Corp |
1,732 |
13.0 |
35.8 |
Hub Group |
1,576 |
12.3 |
27.4 |
Kintetsu World Express |
1,474 |
8.8 |
28.4 |
Echo Global Logistics |
793 |
17.4 |
- |
Eddie Stobart Logistics |
745 |
- |
- |
Logwin |
470 |
5.5 |
26.4 |
Wincanton |
338 |
4.9 |
6.5 |
Hanjin Transportation |
289 |
18.3 |
- |
Sebang |
230 |
8.0 |
9.2 |
Marsden Maritime Holdings |
160 |
186.1 |
22.6 |
K&S Corp |
153 |
5.5 |
42.5 |
TIL Logistics Group |
122 |
|
|
South Port New Zealand |
117 |
10.5 |
18.9 |
Lindsay Australia |
100 |
5.8 |
23.8 |
CTI Logistics |
67 |
5.7 |
20.0 |
Bremer Lagerhaus-Gesellschaft |
69 |
- |
- |
Mercantile Ports and Logistics |
39 |
- |
- |
Hansol Logistics |
32 |
4.5 |
11.1 |
Median |
|
12.1 |
23.2 |
Source: Edison Investment Research, Bloomberg (priced on 7 February 2018)
QEX generated revenues of NZ$22.2m in FY17 (increasing 23% y-o-y), while gross profit increased to NZ$3.8m (up 156%). A good handle on costs resulted in net profits of NZ$1.9m (up from NZ$0.35m in 2016). The company grew strongly.
The company expects this growth to continue, guiding to 17% growth in revenues in 2018 and 8% in 2019. While 2018 will be a year of growth at the top line, the company is investing in new facilities (including the new warehouse), which will increase costs and reduce margins in the near term. However, the increase in the capital base will enable further growth as the company expands into the warehousing space in the coming years.
Dividend policy: the company has no plans to pay dividends in the foreseeable future.
Share listing: the company has a total of 50.3m shares in issue to be listed on the NXT market, although no new shares will be issued at this time. The most recent capital issue in December 2017/January 2018 was held at 25 cents per share (of 10.3m shares, raising NZ$2.575m), implying a total market capitalisation of NZ$12.575m. The new shares were issued at a multiple of 4x EV/EBITDA, which looks attractive given the growth potential.
Exhibit 4: Income statement
NZ$ |
H116 |
H216 |
2016 |
H117 |
H217 |
2017 |
2018e |
2019e |
- Revenue from freight |
5,690,491 |
3,508,851 |
9,199,342 |
3,038,625 |
9,197,467 |
12,236,092 |
|
|
- Revenue from sale of goods |
4,212,075 |
4,708,400 |
8,920,475 |
7,797,656 |
2,200,085 |
9,997,741 |
|
|
Sales turnover (target in future periods) |
9,902,566 |
8,217,251 |
18,119,817 |
10,836,281 |
11,397,552 |
22,233,833 |
26,000,000 |
28,000,000 |
COGS |
(7,086,409) |
(9,534,056) |
(16,620,465) |
(9,333,500) |
(9,055,298) |
(18,388,798) |
|
|
Gross profit |
2,816,157 |
(1,316,805) |
1,499,352 |
1,502,781 |
2,342,254 |
3,845,035 |
3,718,000 |
4,200,000 |
Gross margin |
28% |
(16%) |
8% |
14% |
21% |
17% |
14% |
15% |
Other income - interest received |
27,492 |
(2,933) |
24,559 |
19,440 |
35,542 |
54,982 |
|
|
Admin |
(242,278) |
(164,683) |
(406,961) |
(336,386) |
(220,615) |
(557,001) |
|
|
Employee benefits |
(286,070) |
(230,404) |
(516,474) |
(679,906) |
(44,968) |
(724,874) |
|
|
Depreciation |
(19,938) |
(8,136) |
(28,074) |
(42,805) |
(22,223) |
(65,028) |
|
|
Finance expense on bank overdraft |
0 |
(1,582) |
(1,582) |
(17,611) |
8,669 |
(8,942) |
|
|
Gain on acquisition of subsidiary |
|
0 |
0 |
|
47,879 |
47,879 |
|
|
PBT |
2,295,363 |
(1,724,543) |
570,820 |
445,513 |
2,146,538 |
2,592,051 |
|
|
Taxes |
(643,680) |
426,688 |
(216,992) |
(120,639) |
(595,473) |
(716,112) |
|
|
Profit for year |
1,651,683 |
(1,297,855) |
353,828 |
324,874 |
1,551,065 |
1,875,939 |
|
|
Net profit margin |
16.7% |
-15.8% |
2.0% |
3.0% |
13.6% |
8.4% |
|
|
Source: QEX (historicals and forecasts)
NZ$ |
|
2016 |
H117 |
H217 |
2017 |
2018e |
2019e |
Cash |
|
341,989 |
610,722 |
154,091 |
154,091 |
|
|
Trade and other receivables |
|
665,247 |
2,653,918 |
2,351,041 |
2,351,041 |
|
|
Stock on Hand - finished goods |
|
21,364 |
2,466,342 |
1,275,999 |
1,275,999 |
|
|
Loan shareholder |
|
685,728 |
248,363 |
1,431,000 |
1,431,000 |
|
|
Current assets |
|
1,714,328 |
5,979,345 |
5,212,131 |
5,212,131 |
|
|
PPE |
|
162,176 |
393,954 |
432,997 |
432,997 |
|
|
Deferred tax |
|
22,633 |
47,555 |
50,769 |
50,769 |
|
|
Non-current assets |
|
184,809 |
441,509 |
483,766 |
483,766 |
|
|
Total assets |
|
1,899,137 |
6,420,854 |
5,695,897 |
5,695,897 |
|
|
Trade and other payables |
|
1,306,354 |
1,952,323 |
1,902,522 |
1,902,522 |
|
|
Borrowings |
|
0 |
934,984 |
726,861 |
726,861 |
|
|
Tax payables |
|
212,425 |
932,194 |
810,216 |
810,216 |
|
|
Current liabilities |
|
1,518,779 |
3,819,501 |
3,439,599 |
3,439,599 |
|
|
Total liabilities |
|
1,518,779 |
3,819,501 |
3,439,599 |
3,439,599 |
|
|
Equity |
|
|
|
|
|
|
|
share capital |
|
100 |
101 |
101 |
101 |
|
|
Retained earnings |
|
380,258 |
2,601,252 |
2,256,197 |
2,256,197 |
|
|
Equity |
|
380,358 |
2,601,353 |
2,256,298 |
2,256,298 |
|
|
Source: QEX (historicals and forecasts)
Exhibit 6: Cash flow statement
NZ$ |
H116 |
H216 |
2016 |
H117 |
H217 |
2017 |
2018e |
2019e |
Profit for year |
1,651,683 |
(1,297,855) |
353,828 |
324,874 |
1,551,065 |
1,875,939 |
|
|
Income tax |
643,680 |
(426,688) |
216,992 |
120,639 |
595,473 |
716,112 |
|
|
Depreciation and amortisation |
19,938 |
8,136 |
28,074 |
42,805 |
22,223 |
65,028 |
|
|
(Gain)/loss on acqn/disposal of PPE |
|
4,341 |
4,341 |
|
(47,879) |
(47,879) |
|
|
Interest paid |
0 |
1,582 |
1,582 |
17,611 |
(8,668) |
8,943 |
|
|
Interest received |
(27,492) |
2,933 |
(24,559) |
(19,440) |
(35,542) |
(54,982) |
|
|
Shareholder salary and accruals |
|
155,079 |
155,079 |
|
0 |
|
|
|
Operating cash flows per working capital |
2,287,809 |
(1,552,472) |
735,337 |
486,489 |
2,076,672 |
2,563,161 |
|
|
Movements in debtors |
(1,243,702) |
795,155 |
(448,547) |
(123,678) |
(937,960) |
(1,061,638) |
|
|
Movements in creditors |
(378,688) |
1,103,337 |
724,649 |
609,507 |
(662,107) |
(52,600) |
|
|
Movements in borrowing |
|
|
|
|
|
|
|
|
Movements in deferred tax |
|
|
|
|
|
|
|
|
Movements in inventory |
(200,441) |
195,077 |
(5,364) |
(1,190,343) |
(64,292) |
(1,254,635) |
|
|
Movements in loan to shareholder |
223,530 |
(223,530) |
0 |
(11,501) |
383,907 |
372,406 |
|
|
Cash generated from operations |
688,508 |
317,567 |
1,006,075 |
(229,526) |
796,220 |
566,694 |
|
|
Interest paid |
|
(1,582) |
(1,582) |
(17,216) |
8,274 |
(8,942) |
|
|
Income taxes paid |
(13,583) |
(60,716) |
(74,299) |
4,470 |
(154,027) |
(149,557) |
|
|
Cash flows from operating activities |
674,925 |
255,269 |
930,194 |
(242,272) |
650,467 |
408,195 |
|
|
Property, plant and equipment additions |
(221,848) |
114,319 |
(107,529) |
(3,681) |
(329,111) |
(332,792) |
|
|
Cash received from acquisition of subsidiary |
|
0 |
|
(720,800) |
793,335 |
72,535 |
|
|
Cash flows from investing activities |
(221,848) |
114,319 |
(107,529) |
(724,481) |
464,224 |
(260,257) |
|
|
Proceeds from shareholder |
1,696 |
(1,696) |
0 |
1,215,718 |
(488,857) |
726,861 |
|
|
Payments to shareholder |
(664,426) |
1,139,323 |
474,897 |
(2,535) |
592,650 |
590,115 |
|
|
Payments from trade finance |
|
(1,124,677) |
(1,124,677) |
208,123 |
(1,860,935) |
(1,652,812) |
|
|
Cash flow from financing activities |
(662,730) |
12,950 |
(649,780) |
1,421,306 |
(1,757,142) |
(335,836) |
|
|
Increase in cash and cash equivalents |
(209,653) |
382,538 |
172,885 |
456,631 |
(644,529) |
(187,898) |
|
|
Cash at start of period |
341,989 |
132,336 |
169,104 |
154,091 |
187,898 |
341,989 |
|
|
Cash at end of period |
132,336 |
341,989 |
341,989 |
610,722 |
(456,631) |
154,091 |
|
|
Net debt (cash) at end of period |
0 |
0 |
(341,989) |
324,262 |
572,770 |
572,770 |
|
|
Source: QEX (historicals and forecasts)
Exhibit 7: Other information
Lease commitments, NZ$ |
|
2016 |
2017 |
2018e |
2019e |
Not later than 1 year |
|
133,596 |
133,596 |
|
|
Between 1 and 5 year |
|
276,785 |
143,189 |
|
|
Later than 5 years |
|
|
|
|
|
Total operating lease commitments |
|
410,381 |
276,785 |
|
|
Monthly volume of dairy products exported (NZ to China) |
tonnes |
140 |
146 |
155 |
160 |
Parcels cleared monthly |
# |
59,693 |
60,928 |
66,000 |
72,000 |
Source: QEX (historicals and forecasts)
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority. Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Pty Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com DISCLAIMER This report has been commissioned by NZX Limited (“NZX”) and prepared and issued by Edison Investment Research (NZ) Limited (“Edison”). This report has been prepared independently of NZX and does not represent the opinions of NZX. NZX makes no representation in relation to acquiring, disposing of or otherwise dealing in the securities referred to in this report. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however neither NZX nor Edison guarantees the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in this report may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Investment Research Pty Ltd (Corporate Authorised Representative (1252501) of Myonlineadvisers Pty Ltd (AFSL: 427484)) and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. This research is distributed in the United States by Edison US to major US institutional investors only. Edison US is not registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison US does not offer or provide personalised advice. This research is distributed in New Zealand by Edison). Edison is the New Zealand subsidiary of Edison Investment Research Limited. Edison is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. The distribution of this document in New Zealand is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the New Zealand Financial Advisers Act 2008 (FAA) (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. Edison publishes information about companies in which we believe our readers may be interested, for informational purposes only, and this information reflects our sincere opinions. This report is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, this report should not be construed as a solicitation or inducement to buy, sell, subscribe, or underwrite any securities referred to in this report. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. Edison has a restrictive policy relating to personal dealing. Edison does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, estimates of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. To the maximum extent permitted by law, NZX, Edison, either of their affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. |
Frankfurt +49 (0)69 78 8076 960 Schumannstrasse 34b 60325 Frankfurt Germany |
London +44 (0)20 3077 5700 280 High Holborn London, WC1V 7EE United Kingdom |
New York +1 646 653 7026 295 Madison Avenue, 18th Floor 10017, New York US |
Sydney +61 (0)2 8249 8342 Level 12, Office 1205 95 Pitt Street, Sydney NSW 2000, Australia |
|